![Arun Swaminathan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arun Swaminathan
Chief Executive Officer at
COYA THERAPEUTICS, INC.
Net worth: 45 600 $ as of 31/08/2026
Profile
Dr. Arun Swaminathan is a Chief Executive Officer & Director at Coya Therapeutics, Inc. He is on the Board of Directors at Coya Therapeutics, Inc. Dr. Swaminathan was previously employed as a Chief Business Officer by Actinium Pharmaceuticals, Inc., a Chief Business Officer & Senior Vice President by Alteogen, Inc., a Chief Executive Officer by Lynkogen, Inc., a Director-Worldwide Brand by Bristol Myers Squibb Co., and a Head-Marketing by Labcorp Drug Development, Inc. He received his undergraduate degree from the University of Madras and a doctorate degree from the University of Pittsburgh.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/05/2026 | 10,000 ( 0.04% ) | 45 600 $ | 31/08/2026 |
Arun Swaminathan active positions
| Companies | Position | Start |
|---|---|---|
| COYA THERAPEUTICS, INC. | Chief Executive Officer | 01/11/2024 |
Former positions of Arun Swaminathan
| Companies | Position | End |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2023 |
| ALTEOGEN INC. | Corporate Officer/Principal | 01/09/2021 |
Lynkogen, Inc. | Chief Executive Officer | 01/03/2020 |
| COVANCE INC. | Sales & Marketing | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Training of Arun Swaminathan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
30
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Madras
 University of Madras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Alteogen, Inc.
 Alteogen, Inc. BiotechnologyHealth Technology Engages in the research and development of biopharmaceuticals | Health Technology |
Coya Therapeutics, Inc.
 Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
Lynkogen, Inc. |
- Stock Market
- Insiders
- Arun Swaminathan
